| 18098139
|
Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses. |
J Med Virol |
2008 |
Cello J;Toyoda H;Dejesus N;Dobrikova EY;Gromeier M;Wimmer E |
View
More |
| 20299272
|
Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme. |
Cytokine Growth Factor Rev |
2010 |
Goetz C;Gromeier M |
View
More |
| 21170760
|
Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride. |
Invest New Drugs |
2012 |
Skelding KA;Barry RD;Shafren DR |
View
More |
| 22700951
|
The virus that came in from the cold. |
Sci Transl Med |
2012 |
Bell JC |
View
More |
| 24939611
|
Oncolytic polio virotherapy of cancer. |
Cancer |
2014 |
Brown MC;Dobrikova EY;Dobrikov MI;Walton RW;Gemberling SL;Nair SK;Desjardins A;Sampson JH;Friedman HS;Friedman AH;Tyler DS;Bigner DD;Gromeier M |
View
More |
| 26083317
|
Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus. |
Curr Opin Virol |
2015 |
Brown MC;Gromeier M |
View
More |
| 28829151
|
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas. |
Arch Pathol Lab Med |
2017 |
Chandramohan V;Bryant JD;Piao H;Keir ST;Lipp ES;Lefaivre M;Perkinson K;Bigner DD;Gromeier M;McLendon RE |
View
More |
| 29414253
|
Recombinant Poliovirus for Cancer Immunotherapy. |
Annu Rev Med |
2018 |
Gromeier M;Nair SK |
View
More |
| 29943666
|
Recurrent Glioblastoma Treated with Recombinant Poliovirus. |
N Engl J Med |
2018 |
Desjardins A;Gromeier M;Herndon JE 2nd;Beaubier N;Bolognesi DP;Friedman AH;Friedman HS;McSherry F;Muscat AM;Nair S;Peters KB;Randazzo D;Sampson JH;Vlahovic G;Harrison WT;McLendon RE;Ashley D;Bigner DD |
View
More |
| 30082860
|
Immunotherapy for glioblastoma: going viral. |
Nat Med |
2018 |
Iorgulescu JB;Reardon DA;Chiocca EA;Wu CJ |
View
More |
| 32532329
|
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma. |
J Hematol Oncol |
2020 |
Lupo KB;Matosevic S |
View
More |
| 33875611
|
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. |
J Immunother Cancer |
2021 |
Beasley GM;Nair SK;Farrow NE;Landa K;Selim MA;Wiggs CA;Jung SH;Bigner DD;True Kelly A;Gromeier M;Salama AK |
View
More |
| 34208264
|
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances. |
Viruses |
2021 |
Kwan A;Winder N;Muthana M |
View
More |
| 35674873
|
Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice. |
Neurotherapeutics |
2022 |
Shoaf ML;Desjardins A |
View
More |
